These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28948843)

  • 1. Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues.
    El-Azab AS; Abdel-Aziz AA; Ghabbour HA; Al-Gendy MA
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1229-1239. PubMed ID: 28948843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, antitumor activity and molecular docking study of some novel 3-benzyl-4(3H)quinazolinone analogues.
    Al-Suwaidan IA; Abdel-Aziz AA; Shawer TZ; Ayyad RR; Alanazi AM; El-Morsy AM; Mohamed MA; Abdel-Aziz NI; El-Sayed MA; El-Azab AS
    J Enzyme Inhib Med Chem; 2016; 31(1):78-89. PubMed ID: 25815668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds.
    Mohamed MA; Ayyad RR; Shawer TZ; Abdel-Aziz AA; El-Azab AS
    Eur J Med Chem; 2016 Apr; 112():106-113. PubMed ID: 26890117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: molecular docking study.
    Al-Suwaidan IA; Alanazi AM; Abdel-Aziz AA; Mohamed MA; El-Azab AS
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3935-41. PubMed ID: 23683592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study.
    El-Husseiny WM; El-Sayed MA; Abdel-Aziz NI; El-Azab AS; Ahmed ER; Abdel-Aziz AA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):507-518. PubMed ID: 29455554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and molecular docking studies of 2-(furan-2-yl)quinazolin-4-one derivatives as potential antiproliferative agents.
    Ahmed MF; Belal A
    Arch Pharm (Weinheim); 2015 Jul; 348(7):487-97. PubMed ID: 25921702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies.
    El-Azab AS; Al-Dhfyan A; Abdel-Aziz AA; Abou-Zeid LA; Alkahtani HM; Al-Obaid AM; Al-Gendy MA
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):935-944. PubMed ID: 28718672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies.
    Alanazi AM; Abdel-Aziz AA; Shawer TZ; Ayyad RR; Al-Obaid AM; Al-Agamy MH; Maarouf AR; El-Azab AS
    J Enzyme Inhib Med Chem; 2016 Oct; 31(5):721-35. PubMed ID: 26162029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cytotoxicity testing of novel 2-(3-substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones.
    Pomarnacka E; Maruszak M; Langowska K; Reszka P; Bednarski PJ
    Arch Pharm (Weinheim); 2008 Aug; 341(8):485-90. PubMed ID: 18618486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones.
    Abdel-Aziz AA; Abou-Zeid LA; ElTahir KEH; Ayyad RR; El-Sayed MA; El-Azab AS
    Eur J Med Chem; 2016 Oct; 121():410-421. PubMed ID: 27318118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
    Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA
    Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and
    Le Y; Gan Y; Fu Y; Liu J; Li W; Zou X; Zhou Z; Wang Z; Ouyang G; Yan L
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):555-564. PubMed ID: 31967481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors.
    Mowafy S; Farag NA; Abouzid KA
    Eur J Med Chem; 2013 Mar; 61():132-45. PubMed ID: 23142066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential anti-proliferative agents from 1,4-benzoxazinone-quinazolin-4(3H)-one templates.
    Bollu R; Banu S; Kasaboina S; Bantu R; Nagarapu L; Polepalli S; Jain N
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5481-5484. PubMed ID: 29089233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study.
    El-Sayed MA; El-Husseiny WM; Abdel-Aziz NI; El-Azab AS; Abuelizz HA; Abdel-Aziz AA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):199-209. PubMed ID: 29251017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones.
    Abdel Gawad NM; Georgey HH; Youssef RM; El-Sayed NA
    Eur J Med Chem; 2010 Dec; 45(12):6058-67. PubMed ID: 21051122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors.
    Alsaid MS; Al-Mishari AA; Soliman AM; Ragab FA; Ghorab MM
    Eur J Med Chem; 2017 Dec; 141():84-91. PubMed ID: 29028534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis.
    El-Azab AS; Abdel-Aziz AA; AlSaif NA; Alkahtani HM; Alanazi MM; Obaidullah AJ; Eskandrani RO; Alharbi A
    Bioorg Chem; 2020 Nov; 104():104345. PubMed ID: 33142413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
    Zayed MF; Ahmed S; Ihmaid S; Ahmed HEA; Rateb HS; Ibrahim SRM
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis and Antitumor Activities of Novel Quinazolinone Derivatives as Potential EGFR Inhibitors.
    Wang J; Huang L; Chen X; Yuan Y; Sun J; Yang M
    Chem Pharm Bull (Tokyo); 2022; 70(9):637-641. PubMed ID: 36047235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.